ArcStone Kingswood Names Karen Sterling, PhD, CFA Head of Biotechnology Investment Banking

Move builds out ArcStone Kingswood's healthcare and biotechnology presence as the firm expands its U.S. franchiseNew York, New York and Toronto, Ontario--(Newsfile Corp. - July 22, 2026) - ArcStone Kingswood, a branded branch office of Kingswood Capital Partners, LLC (member FINRA/SIPC), today announced that Karen Sterling, PhD, CFA has been named Head of Biotechnology Investment Banking within the firm.Healthcare represents a significant share of the Nasdaq, and Dr. Sterling's appointment...